Subject: Health Logic News Release
Word Document
File: '\\swfile\EmailIn\20240322 130952 Attachment 20240322 - Health Logic NR - Financing Extension & Resignation (FINAL).docx'
1393-7351-7835, v. 1
Health Logic Interactive Announces Extension of Non-Brokered Private Placement and Director Change
CALGARY, AB, March 22, 2024 - Health Logic Interactive Inc. ("Health Logic" or the "Company") (TSXV: CHIP.H) (OTCPK: CHYPF), a Company in the search of licensing and acquisition opportunities, is announcing the extension of their offer for sale of securities of the Company (the "Offering"), on a non-brokered private placement basis, as originally announced by news release on February 2, 2024.
For full details respecting the Offering, please refer to the news release: here
It is anticipated that closing of the Offering will occur no later than April 5, 2024. The Offering is subject to the receipt of all necessary approvals, including approval of the TSX Venture Exchange (the "TSXV") and satisfaction of other customary closing conditions.
Health Logic also announces the resignation of Mr. Gregg Jensen from the Board of Directors. The Company thanks Mr. Jensen for his time and wishes him the best in his future endeavours. The Company also announces that it has appointed Ryan Hounjet to its Board of Directors. Mr. Hounjet brings significant public markets experience to the team, and the Company is looking forward to his contributions as a Board member.
Mr. Hounjet is an experienced entrepreneur and capital markets adviser with a focus on building start-ups, corporate development, investor relations and corporate finance in both the Canadian and United States public markets. Mr. Hounjet worked on the Scotiabank Commercial Banking team from 2019 to 2022, specializing in commercial lending and providing complex capital solutions tailored for his clients' needs while building deep, trusting relationships. Mr. Hounjet then moved into the public markets with Univest Securities (Canada) in early 2022 to help launch and develop its Vancouver office. Through Univest, Mr. Hounjet has advised various private companies on capital market solutions, and provided guidance on public listings on the Canadian Securities Exchange, the TSXV and the Nasdaq. Mr. Hounjet prides himself on continuous education. He earned his BSc with a major in biochemistry from the University of British Columbia and holds the Chartered Financial Analyst designation.
About Health Logic Interactive Inc.
Health Logic is a public entity on the NEX board of the TSX-V and intends to pursue its search for new assets to develop.
Further information regarding Health Logic and its disclosure documents are available on the Company's profile at www.sedarplus.ca.
Disclaimer and Cautionary Notes
Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, are forward-looking statements including statements related to the Offering as well as the Company's intention to search for new assets to develop. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. For example, there is no guarantee that the Company will be able to complete the Offering or that adequate funds will be raised to pursue the Company's objectives. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.
SOURCE Health Logic Interactive Inc.
Harrison Ross, CEO, (1-778)-870-5051, harrison@healthlogicinteractive.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
© 2026 Canjex Publishing Ltd. All rights reserved.